CompoAtlas

ZinoB+

ZinoB+, licence 80150256: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
ZinoB, ZinoB plus, Zinzino ZinoB+
Licence holder
Zinzino AB
NPN or DIN-HM
80150256
Status
Active licence
Licence date
7 August 2026
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Plantago ovata0.25 gNot calculated
Zea mays

Source : Zea mays - Graine

2.6 gNot calculated
Solanum tuberosum

Source : Solanum tuberosum - Tubercule

0.3 gNot calculated
Fructooligosaccharides

Source : Cichorium intybus - racine

100.0 mgNot calculated
bêta-D-glucane

Source : Avena sativa - Graine

1500.0 mgNot calculated
Inuline

Source : Cichorium intybus - racine

0.9 gNot calculated

Non-medicinal ingredients

Fruit de Musa acuminata, Gomme de Guar partiellement hydrolysée

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)1.0 Mesures3.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps reduce/lower LDL cholesterol (which is one risk factor for the development of coronary heart disease). Helps reduce/lower bad cholesterol (which is one risk factor for the development of coronary heart disease). Helps support and maintain a healthy digestive system. Provides support for healthy (postprandial) glucose metabolism (within two hours after a meal). Source of fiber for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80150256

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line